iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Indoco Partners with Clarity Pharma to Launch 20 Affordable Drugs in UK

4 Dec 2024 , 01:37 PM

Indoco Remedies Ltd has signed an agreement with Clarity Pharma, the UK-based distributor, to capture a larger share of the UK pharmaceutical market. Within the next 18 months, Indoco Remedies will launch about 20 pharmaceutical products in the UK.

Clarity Pharma would distribute the products with excellent market knowledge and network. Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.

Aditi Panandikar, managing director of Indoco Remedies, said that this collaboration is a landmark event for the company in further deepening its presence in the UK pharma market. According to Panandikar, the partnership combines the portfolio of affordable, high-quality pharmaceuticals from Indoco with the robust distribution capabilities of Clarity Pharma.

Steve Soper, CEO of Clarity Pharma, said that he was excited about the partnership, which was the culmination of years of effort in developing a strategic market access plan. According to Soper, the launch of Indoco’s products in the UK will save costs and make medicines more affordable for a larger number of patients. This collaboration is to provide innovative healthcare solutions while ensuring long-term growth and collaboration.

Related Tags

  • Clarity Pharma
  • Indoco
  • Indoco Remedies
  • Pharma
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Dabur Faces ₹110.33 Crore Tax Demand
1 Apr 2025|11:10 PM
Tata Motors Sees 3% Rise in PV Sales
1 Apr 2025|10:56 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.